EUVIMEDEUVIMED entdecken
Leserbrief

Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?

Aoba Okeya, Akihiko Shimomura iD, Dai Kitagawa iD, Chikako Shimizu iD

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.24.00992 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Aoba Okeya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aoba Okeya, MD, Department of Breast Surgical Oncology, National Center for Global Health and Medicine, Tokyo, Japan; Akihiko Shimomura, MD, PhD, Dep…. Hauptthemen laut MEDLINE: Breast Neoplasms, Estrogen Receptor alpha, Erb-b2 Receptor Tyrosine Kinases, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEstrogen Receptor alphaErb-b2 Receptor Tyrosine KinasesMutationHumansFemaleAdministration, OralSelective Estrogen Receptor Modulators

Substanzen

Estrogen Receptor alphaErb-b2 Receptor Tyrosine KinasesSelective Estrogen Receptor ModulatorsESR1 protein, humanERBB2 protein, human

Autor:innen und Institutionen

  • Aoba Okeya, MD, Department of Breast Surgical Oncology, National Center for Global Health and Medicine, Tokyo, Japan; Akihiko Shimomura, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Hea…

ORCID-Profile: Akihiko Shimomura, Dai Kitagawa, Chikako Shimizu

Zitieren

APA

Okeya, A., Shimomura, A., Kitagawa, D., & Shimizu, C. (2024). Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00992

Vancouver

Okeya A, Shimomura A, Kitagawa D, Shimizu C. Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00992

BibTeX
@article{Okeya2024,
  author = {Okeya, Aoba and Shimomura, Akihiko and Kitagawa, Dai and Shimizu, Chikako},
  title = {Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.24.00992}
}
Kostenlos starten →